These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18834434)

  • 1. An examination of beta-cell function measures and their potential use for estimating beta-cell mass.
    Kahn SE; Carr DB; Faulenbach MV; Utzschneider KM
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():63-76. PubMed ID: 18834434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.
    Thamer C; Haap M; Heller E; Joel L; Braun S; Tschritter O; Haring H; Fritsche A
    Horm Metab Res; 2006 Mar; 38(3):178-82. PubMed ID: 16673209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of non-glucose versus glucose stimulation test in estimating islet β-cell function in individuals with differential glucose tolerance].
    He Y; Wang C; Li F; Gheng H; Yan L
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):760-3. PubMed ID: 23755814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
    Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function.
    Byrne MM; Sturis J; Sobel RJ; Polonsky KS
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E572-9. PubMed ID: 8928761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward an integrated phenotype in pre-NIDDM.
    Bergman RN; Watanabe R; Rebrin K; Ader M; Steil G
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S67-77. PubMed ID: 8894486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
    Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
    Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
    Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
    Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impaired insulin secretion in isolated islets of Goto-Kakizaki rats, an animal model of non obese type 2 diabetes, is a primary event].
    Seiça RM; Suzuki KI; Santos RM; Do Rosário LM
    Acta Med Port; 2004; 17(1):42-8. PubMed ID: 15636726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in insulin secretion in type 2 diabetes mellitus.
    Guillausseau PJ; Meas T; Virally M; Laloi-Michelin M; Médeau V; Kevorkian JP
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S43-8. PubMed ID: 18640585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
    Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
    J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Cell function in type 2 diabetes.
    Ferrannini E; Mari A
    Metabolism; 2014 Oct; 63(10):1217-27. PubMed ID: 25070616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
    Abdul-Ghani MA; Tripathy D; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1130-9. PubMed ID: 16644654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta- and alpha-cell dysfunction in type 2 diabetes.
    Del Prato S; Marchetti P
    Horm Metab Res; 2004; 36(11-12):775-81. PubMed ID: 15655708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta cell failure: causes and consequences.
    Kahn SE
    Int J Clin Pract Suppl; 2001 Sep; (123):13-8. PubMed ID: 11594291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.